Yasuaki Arai
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications
Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study.
Journal: The Lancet. Oncology
Published: May 08, 2026
Challenges in Randomized Trials in Palliative Interventional Radiology: Lessons from a Percutaneous Osteoplasty Trial (JIVROSG-0804) Discontinued for Poor Accrual.
Journal: Journal of vascular and interventional radiology : JVIR
Published: December 10, 2025
Caudally directed posterior high-dose-rate brachytherapy for reirradiation of para-aortic lymph node recurrence: A technical innovation enabled by interventional radiology.
Journal: Brachytherapy
Published: August 10, 2025
The Impact of Interventional Radiology Educational Webinars during the Coronavirus Disease 2019 Pandemic and Beyond-The Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR) Experience.
Journal: Interventional radiology (Higashimatsuyama-shi (Japan)
Published: July 15, 2025
The Fun of Building from Zero: 2025 Gold Medalist Commentary.
Journal: Journal of vascular and interventional radiology : JVIR
Published: May 16, 2025
Hybrid procedure suites: combining computed tomography and conventional angiography.
Journal: The British journal of radiology
Published: February 06, 2025
Prospective Multicenter Observational Study of Silent Brain Infarction following Transradial Hepatic Intervention (The MOSAIC Study).
Journal: Journal of vascular and interventional radiology : JVIR
Published: February 04, 2025
Risk factors of non-diagnostic percutaneous liver tumor biopsy: a single-center retrospective analysis of 938 biopsies based on cause of error.
Journal: Japanese journal of radiology
Published: August 08, 2024
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Journal: Lancet (London, England)
Published: August 06, 2024
Safety of propofol sedation administered by interventional radiologists for radiofrequency ablation in patients with hepatocellular carcinoma.
Journal: Japanese journal of radiology
Published: February 14, 2024
Feasibility and safety of direct percutaneous embolization of lymphopseudoaneurysm for postoperative lymphatic leakage.
Journal: Journal of medical imaging and radiation oncology
Published: February 04, 2024
Last Updated: 09/26/2026